Mark A. Demitrack

Publications

• Durability of Clinical Benefit with Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Major Depression: Assessment of Relapse During a 6-month, Multisite, Open-label Study
  Brain Stimulation. Oct, 2010  |   Pubmed ID: 20965447
• Reply Regarding "efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: a Multisite Randomized Controlled Trial"
  Biological Psychiatry. Jan, 2010  |   Pubmed ID: 19914602
• Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
  Psychopharmacology Bulletin. 2009  |   Pubmed ID: 19629020
• Cost-effectiveness of Transcranial Magnetic Stimulation in the Treatment of Major Depression: a Health Economics Analysis
  Advances in Therapy. Mar, 2009  |   Pubmed ID: 19330495
• Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-label Extension Trial
  The Journal of Clinical Psychiatry. Mar, 2008  |   Pubmed ID: 18294022
• Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: a Comprehensive Summary of Safety Experience from Acute Exposure, Extended Exposure, and During Reintroduction Treatment
  The Journal of Clinical Psychiatry. Feb, 2008  |   Pubmed ID: 18232722
• Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: a Multisite Randomized Controlled Trial
  Biological Psychiatry. Dec, 2007  |   Pubmed ID: 17573044
• Clinical Methodology and Its Implications for the Study of Therapeutic Interventions for Chronic Fatigue Syndrome: a Commentary
  Pharmacogenomics. Apr, 2006  |   Pubmed ID: 16610962
• Duloxetine in the Acute and Long-term Treatment of Major Depressive Disorder: a Placebo- and Paroxetine-controlled Trial
  European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. Dec, 2004  |   Pubmed ID: 15589385
• Duloxetine in the Treatment of Depression: a Double-blind Placebo-controlled Comparison with Paroxetine
  Journal of Clinical Psychopharmacology. Aug, 2004  |   Pubmed ID: 15232330
• Basal Circadian and Pulsatile ACTH and Cortisol Secretion in Patients with Fibromyalgia And/or Chronic Fatigue Syndrome
  Brain, Behavior, and Immunity. Jul, 2004  |   Pubmed ID: 15157948
• Effects of Duloxetine on Painful Physical Symptoms Associated with Depression
  Psychosomatics. Jan-Feb, 2004  |   Pubmed ID: 14709757
• Can Monoamine-based Therapies Be Improved?
  The Journal of Clinical Psychiatry. 2002  |   Pubmed ID: 15453009
• Duloxetine 60 Mg Once Daily Dosing Versus Placebo in the Acute Treatment of Major Depression
  Journal of Psychiatric Research. Nov-Dec, 2002  |   Pubmed ID: 12393307
• Duloxetine, 60 Mg Once Daily, for Major Depressive Disorder: a Randomized Double-blind Placebo-controlled Trial
  The Journal of Clinical Psychiatry. Apr, 2002  |   Pubmed ID: 12000204
• The Tyramine Pressor Test May Have Limited Sensitivity, Especially in the Presence of Dual Serotonin/norepinephrine Uptake Inhibition
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. May, 2002  |   Pubmed ID: 11927196
• Duloxetine in the Treatment of Major Depressive Disorder: a Double-blind Clinical Trial
  The Journal of Clinical Psychiatry. Mar, 2002  |   Pubmed ID: 11926722